Article Information
History
- August 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Charles S. Venuto, PharmD1,2,*,
- Konnor Herbst, MA1,
- Lana M. Chahine, MD3 and
- Karl Kieburtz, MD, MPH1,2
- 1Center for Health + Technology, University of Rochester, Rochester, NY, USA
- 2Department of Neurology, University of Rochester, Rochester, NY, USA
- 3Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
- ↵*Correspondence to: Charles S. Venuto, Center for Health + Technology, University of Rochester, 265 Crittenden Blvd., Rochester, NY 14642; Telephone: 585-276-5622; E-mail: Charles.Venuto{at}chet.rochester.edu
Posted August 08, 2024.
Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data
